ArticleJACC. Asia2025
Temporal Trends in Utilization of Transvenous Lead Extractions Among Cardiac Implantable Electronic Device Infections.
Article in JACC. Asia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac implantable electronic device (CIED) infections are a growing concern, leading to significant morbidity and mortality. International guidelines recommend complete device and lead extraction for infected cases, yet real-world adherence to these recommendations remains suboptimal. The use of transvenous lead extraction (TLE) in Japan has not been well characterized.
objectivesThis study aimed to investigate the real-world use of TLE in CIED infections, assess trends over time, and identify factors associated with the likelihood of undergoing TLE and the procedural complications.
methodsThis was a retrospective observational study using the Japanese Registry of All Cardiac and Vascular Diseases diagnosis procedure combination/per diem payment system (JROAD-DPC) from 2015 to 2021. Patients with a diagnosis of CIED infections were identified on the basis of the International Classification of Diseases, 10th revision codes.
resultsAmong 7,434 hospitalization records, only 38% underwent TLE for CIED infections in the overall hospitals. However, the use of TLE in certified TLE hospitals increased significantly from 54.0% in 2015 to 70.8% in 2021 (P trend <0.001). Independent predictors of reduced TLE use included a lower body mass index, female sex, cerebrovascular disease, and dementia. Notably, 65.5% of patients in noncertified hospitals were discharged home, a finding suggesting potential undertreatment.
conclusionsAlthough the TLE rate is increasing, many patients with CIED infections do not undergo TLE. Addressing barriers through physician education, improved referral systems, and adherence to guideline-directed management, especially in noncertified hospitals, is essential for optimizing the TLE rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.